Chemo Biological

ASENSIA-400 TABLETS

ASENSIA-400 TABLETS

Product Details :

Feature Details
Product Name ASENSIA-400 Tablets
Form Tablets (Oral, Delayed Release)
Key Ingredient Mesalamine (Mesalazine) 400 mg
Core Benefits Treats and maintains remission in ulcerative colitis and Crohn’s disease
Mechanism of Action Anti-inflammatory action in the colon by inhibiting prostaglandin synthesis
Support Areas Inflammatory Bowel Disease (IBD), Ulcerative Colitis, Proctitis

Composition: S Adenosyl Methionine 400mg Packing: 10X10 Alu-Alu

Description : ASENSIA-400 Tablets contain Mesalamine (Mesalazine) 400 mg, an anti-inflammatory agent used primarily for the treatment and maintenance of ulcerative colitis and Crohn’s disease. It works by acting locally in the colon to reduce inflammation, pain, and diarrhea associated with inflammatory bowel diseases (IBD). ASENSIA-400 helps maintain remission and prevent flare-ups. It is well-tolerated and can be used long-term under medical supervision. Ideal for patients requiring gastrointestinal-specific anti-inflammatory therapy without systemic side effects.

Send Enquiry & Get Best Quote

Fill out the form below to connect with our experts to get best price and deals on our bulk products 

Expertise You Can Count On

At Chemo Biologicals, trust is built on decades of proven expertise. With over 43 years of industry experience, we bring unmatched knowledge, precision, and professionalism to every aspect of our operations. Our team of experts—ranging from skilled pharmacists to regulatory specialists—ensures that every product meets the highest standards of quality, safety, and compliance.

Whether you’re partnering with us for PCD Pharma Franchise or Third-Party Manufacturing, you can rely on our deep understanding of the pharmaceutical landscape, robust infrastructure, and ethical business approach. We don’t just deliver medicines—we deliver confidence, consistency, and care.

Choose Chemo Biologicals — where experience drives excellence and expertise earns your trust.

Error: Contact form not found.